{"id":"https://openalex.org/W2725302","doi":"https://doi.org/10.1023/a:1007739025010","title":"Studies on the Mechanism Underlying the Antifibrillatory Effect of the A1-Adenosine Agonist, R-PIA, in Rat Isolated Hearts","display_name":"Studies on the Mechanism Underlying the Antifibrillatory Effect of the A1-Adenosine Agonist, R-PIA, in Rat Isolated Hearts","alternate_titles":[],"publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2725302","doi":"https://doi.org/10.1023/a:1007739025010","mag":"2725302","pmid":"https://pubmed.ncbi.nlm.nih.gov/9493706"},"language":"en","primary_location":{"id":"doi:10.1023/a:1007739025010","doi":"https://doi.org/10.1023/a:1007739025010","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1007739025010","pdf_url":null,"source":{"id":"https://openalex.org/S131791641","display_name":"Cardiovascular Drugs and Therapy","issn_l":"0920-3206","issn":["0920-3206","1573-7241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Drugs and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2725302"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083939564","display_name":"Cherry L. Wainwright","orcid":"https://orcid.org/0000-0003-1404-965X","observed_orcids":["https://orcid.org/0000-0003-1404-965X"]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cherry L. Wainwright","raw_affiliation_strings":["Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK. c.I.wainwright@strath.ac.uk","Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK. c.I.wainwright@strath.ac.uk","institution_ids":["https://openalex.org/I181647926"]},{"raw_affiliation_string":"Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Liping Kang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Liping Kang","raw_affiliation_strings":["Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK","institution_ids":["https://openalex.org/I181647926"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110075713","display_name":"Sean A. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181647926","display_name":"University of Strathclyde","ror":"https://ror.org/00n3w3b69","country_code":"GB","type":"education","lineage":["https://openalex.org/I181647926"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sean Ross","raw_affiliation_strings":["Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Physiology & Pharmacology, University of Strathclyde, Glasgow, Scotland, UK","institution_ids":["https://openalex.org/I181647926"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I181647926"],"apc_list":{"value":4490,"currency":"USD","value_usd":4490},"apc_paid":null,"fwci":0.2964,"has_fulltext":false,"cited_by_count":6,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.42565598,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"11","issue":"5","first_page":"669","last_page":"678"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.7738999724388123,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.7738999724388123,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.20640000700950623,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/r-pia","display_name":"R-PIA","score":0.8840000033378601},{"id":"https://openalex.org/keywords/adenosine-a1-receptor-agonist","display_name":"adenosine A1 receptor agonist","score":0.824999988079071},{"id":"https://openalex.org/keywords/antifibrillatory-effect","display_name":"antifibrillatory effect","score":0.9039999842643738},{"id":"https://openalex.org/keywords/ventricular-fibrillation","display_name":"ventricular fibrillation","score":0.8489999771118164},{"id":"https://openalex.org/keywords/ventricular-arrhythmias","display_name":"ventricular arrhythmias","score":0.8220000267028809},{"id":"https://openalex.org/keywords/myocardial-ischemia","display_name":"myocardial ischemia","score":0.9179999828338623},{"id":"https://openalex.org/keywords/coronary-artery-occlusion","display_name":"coronary artery occlusion","score":0.765999972820282},{"id":"https://openalex.org/keywords/bradycardia","display_name":"bradycardia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hemodynamic-response","display_name":"hemodynamic response","score":0.4490000009536743},{"id":"https://openalex.org/keywords/premature-ventricular-contractions","display_name":"premature ventricular contractions","score":0.7400000095367432},{"id":"https://openalex.org/keywords/antiarrhythmic-therapy","display_name":"antiarrhythmic therapy","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9179607033729553},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.6978291273117065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6396454572677612},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.6031755805015564},{"id":"https://openalex.org/C2777495988","wikidata":"https://www.wikidata.org/wiki/Q217111","display_name":"Bradycardia","level":4,"score":0.5977014303207397},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5730111598968506},{"id":"https://openalex.org/C2781005686","wikidata":"https://www.wikidata.org/wiki/Q848662","display_name":"Ventricular fibrillation","level":2,"score":0.5535368919372559},{"id":"https://openalex.org/C2780393670","wikidata":"https://www.wikidata.org/wiki/Q5172192","display_name":"Coronary occlusion","level":3,"score":0.5366430282592773},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.45268407464027405},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.451903760433197},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.44609785079956055},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.43083077669143677},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.2409020960330963},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18362322449684143}],"mesh":[{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014693","descriptor_name":"Ventricular Fibrillation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015428","descriptor_name":"Myocardial Reperfusion Injury","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058906","descriptor_name":"Purinergic P1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1023/a:1007739025010","doi":"https://doi.org/10.1023/a:1007739025010","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1007739025010","pdf_url":null,"source":{"id":"https://openalex.org/S131791641","display_name":"Cardiovascular Drugs and Therapy","issn_l":"0920-3206","issn":["0920-3206","1573-7241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular Drugs and Therapy","raw_type":"journal-article"},{"id":"pmid:9493706","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9493706","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cardiovascular drugs and therapy","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W5669640","https://openalex.org/W158256711","https://openalex.org/W1516288804","https://openalex.org/W1517555757","https://openalex.org/W1525397595","https://openalex.org/W1932075957","https://openalex.org/W1970392387","https://openalex.org/W1973838189","https://openalex.org/W1983069528","https://openalex.org/W1983087874","https://openalex.org/W1987664769","https://openalex.org/W2005360259","https://openalex.org/W2007136845","https://openalex.org/W2014709197","https://openalex.org/W2020093115","https://openalex.org/W2024197930","https://openalex.org/W2049116802","https://openalex.org/W2065100943","https://openalex.org/W2069992978","https://openalex.org/W2073242964","https://openalex.org/W2074730407","https://openalex.org/W2076129331","https://openalex.org/W2077446062","https://openalex.org/W2084839593","https://openalex.org/W2088619634","https://openalex.org/W2101755160","https://openalex.org/W2118527541","https://openalex.org/W2133488495","https://openalex.org/W2137171780","https://openalex.org/W2148706434","https://openalex.org/W2171680307","https://openalex.org/W2248420142","https://openalex.org/W2315783996","https://openalex.org/W2402623645","https://openalex.org/W2404919515","https://openalex.org/W2419589412"],"related_works":["https://openalex.org/W2073242964","https://openalex.org/W2000120160","https://openalex.org/W2030711417","https://openalex.org/W158256711","https://openalex.org/W2028267932","https://openalex.org/W2007136845","https://openalex.org/W2144104801","https://openalex.org/W2047164106","https://openalex.org/W2073902635"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2725302","counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
